We studied therapeutic efficacy and migration characteristics of mesenchymal stem cells isolated from the human placenta after their intracerebral (stereotactic) administration to rats with the experimental ischemic stroke. It was shown that cell therapy significantly improved animal survival rate and reduced the severity of neurological deficit. New data on the migration pathways of transplanted cells in the brain were obtained.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Han Y, Li X, Zhang Y, Han Y, Chang F, Ding J. Mesenchymal Stem Cells for Regenerative Medicine. Cells. 2019;8(8):886. https://doi.org/10.3390/cells8080886.
Li W, Shi L, Hu B, Hong Y, Zhang H, Li X, Zhang Y. Mesenchymal stem cell-based therapy for stroke: current understanding and challenges. Front. Cell Neurosci. 2021;15:628940. https://doi.org/10.3389/fncel.2021.628940
Wang F, Tang H, Zhu J, Zhang J.H. Transplanting mesenchymal stem cells for treatment of ischemic stroke. Cell Transplant. 2018;27(12):1825-1834. https://doi.org/10.1177/0963689718795424
Lukomska B, Stanaszek L, Zuba-Surma E, Legosz P, Sarzynska S, Drela K. Challenges and controversies in human mesenchymal stem cell therapy. Stem Cells Int. 2019;2019:9628536. https://doi.org/10.1155/2019/9628536
Namestnikova DD, Tairova RT, Sukhinich KK, Cherkashova EA, Gubskiy IL, Gubskiy LV, Yarygin KN. Cell therapy for ischemic stroke. Stem cell types and results of pre-clinical trials. Zh. Nevrol. Psikhiatr. Im. S.S.Korsakova. 2018;118(9, Vyp. 2):69-75. https://doi.org/10.17116/jnevro201811809269
Sarmah D, Agrawal V, Rane P, Bhute S, Watanabe M, Kalia K, Ghosh Z, Dave KR, Yavagal DR, Bhattacharya P. Mesenchymal stem cell therapy in ischemic stroke: a meta-analysis of preclinical studies. Clin. Pharmacol. Ther. 2018;103(6):990-998. https://doi.org/10.1002/cpt.927
Borlongan CV. Concise review: stem cell therapy for stroke patients: are we there yet? Stem Cells Transl. Med. 2019;8(9):983-988. https://doi.org/10.1002/sctm.19-0076
Jingli Y, Jing W, Saeed Y. Ischemic brain stroke and mesenchymal stem cells: an overview of molecular mechanisms and therapeutic potential. Stem Cells Int. 2022;2022:5930244. https://doi.org/10.1155/2022/5930244
Lalu MM, Montroy J, Dowlatshahi D, Hutton B, Juneau P, Wesch N, Zhang SY, McGinn R, Corbett D, Stewart DJ, Fergusson DA. From the lab to patients: a systematic review and meta-analysis of mesenchymal stem cell therapy for stroke. Transl. Stroke Res. 2020;11(3):345-364. https://doi.org/10.1007/s12975-019-00736-5
Sanchez-Diaz M, Quiñones-Vico MI, Sanabria de la Torre R, Montero-Vílchez T, Sierra-Sánchez A, Molina-Leyva A, Arias-Santiago S. Biodistribution of mesenchymal stromal cells after administration in animal models and humans: a systematic review. J. Clin. Med. 2021;10(13):2925. https://doi.org/10.3390/jcm10132925
Zheng H, Zhang B, Chhatbar PY, Dong Y, Alawieh A, Lowe F, Hu X, Feng W. Mesenchymal stem cell therapy in stroke: a systematic review of literature in pre-clinical and clinical research. Cell Transplant. 2018;27(12):1723-1730. https://doi.org/10.1177/0963689718806846
Zhang HL, Xie XF, Xiong YQ, Liu SM, Hu GZ, Cao WF, Wu XM. Comparisons of the therapeutic effects of three different routes of bone marrow mesenchymal stem cell transplantation in cerebral ischemic rats. Brain Res. 2018;1680:143-154. https://doi.org/10.1016/j.brainres.2017.12.017
Brooks B, Ebedes D, Usmani A, Gonzales-Portillo JV, Gonzales-Portillo D, Borlongan CV. Mesenchymal Stromal Cells in Ischemic Brain Injury. Cells. 2022;11(6):1013. https://doi.org/10.3390/cells11061013
Cherkashova EA, Namestnikova DD, Gubskiy IL, Revkova VA, Sukhinich KK, Mel’nikov PA, Chekhonin VP, Gubsky LV, Yarygin KN. Dose-dependent effects of intravenous mesenchymal stem cell transplantation in rats with acute focal cerebral ischemia. Bull. Exp. Biol. Med. 2022;173(4):514-518. https://doi.org/10.1007/s10517-022-05573-5
Sammali E, Alia C, Vegliante G, Colombo V, Giordano N, Pischiutta F, Boncoraglio GB, Barilani M, Lazzari L, Caleo M, De Simoni MG, Gaipa G, Citerio G, Zanier ER. Intravenous infusion of human bone marrow mesenchymal stromal cells promotes functional recovery and neuroplasticity after ischemic stroke in mice. Sci. Rep. 2017;7(1):6962. https://doi.org/10.1038/s41598-017-07274-w
Fischer UM, Harting MT, Jimenez F, Monzon-Posadas WO, Xue H, Savitz SI, Laine GA, Cox CS Jr. Pulmonary passage is a major obstacle for intravenous stem cell delivery: the pulmonary first-pass effect. Stem Cells Dev. 2009;18(5):683-692. https://doi.org/10.1089/scd.2008.0253
Gao J, Dennis JE, Muzic RF, Lundberg M, Caplan AI. The dynamic in vivo distribution of bone marrow-derived mesenchymal stem cells after infusion. Cells Tissues Organs. 2001;169(1):12-20. https://doi.org/10.1159/000047856
Scarfe L, Taylor A, Sharkey J, Harwood R, Barrow M, Comenge J, Beeken L, Astley C, Santeramo I, Hutchinson C, Ressel L, Smythe J, Austin E, Levy R, Rosseinsky MJ, Adams DJ, Poptani H, Park BK, Murray P, Wilm B. Non-invasive imaging reveals conditions that impact distribution and persistence of cells after in vivo administration. Stem Cell Res. Ther. 2018;9(1):332. https://doi.org/10.1186/s13287-018-1076-x
Schrepfer S, Deuse T, Reichenspurner H, Fischbein MP, Robbins RC, Pelletier MP. Stem cell transplantation: the lung barrier. Transplant Proc. 2007;39(2):573-576. https://doi.org/10.1016/j.transproceed.2006.12.019
Li Y, Chen J, Wang L, Lu M, Chopp M. Treatment of stroke in rat with intracarotid administration of marrow stromal cells. Neurology. 2001;56(12):1666-1672. https://doi.org/10.1212/wnl.56.12.1666
Namestnikova DD, Gubskiy IL, Revkova VA, Sukhinich KK, Melnikov PA, Gabashvili AN, Cherkashova EA, Vishnevskiy DA, Kurilo VV, Burunova VV, Semkina AS, Abakumov MA, Gubsky LV, Chekhonin VP, Ahlfors JE, Baklaushev VP, Yarygin KN. Intra-arterial stem cell transplantation in experimental stroke in rats: Real-Time MR visualization of transplanted cells starting with their first pass through the brain with regard to the therapeutic action. Front. Neurosci. 2021;15:641970. https://doi.org/10.3389/fnins.2021.641970
Guzman R, Janowski M, Walczak P. Intra-arterial delivery of cell therapies for stroke. Stroke. 2018;49(5):1075-1082. https://doi.org/10.1161/STROKEAHA.117.018288
Yarygin KN, Namestnikova DD, Sukhinich KK, Gubskiy IL, Majouga AG, Kholodenko IV. Cell therapy of stroke: do the intra-arterially transplanted mesenchymal stem cells cross the blood-brain barrier? Cells. 2021;10(11):2997. https://doi.org/10.3390/cells10112997
Kawabori M, Kuroda S, Sugiyama T, Ito M, Shichinohe H, Houkin K, Kuge Y, Tamaki N. Intracerebral, but not intravenous, transplantation of bone marrow stromal cells enhances functional recovery in rat cerebral infarct: an optical imaging study. Neuropathology. 2012;32(3):217-226. https://doi.org/10.1111/j.1440-1789.2011.01260.x
Boltze J, Arnold A, Walczak P, Jolkkonen J, Cui L, Wagner DC. The dark side of the force — constraints and complications of cell therapies for stroke. Front. Neurol. 2015;6:155. https://doi.org/10.3389/fneur.2015.00155
Bao X, Wei J, Feng M, Lu S, Li G, Dou W, Ma W, Ma S, An Y, Qin C, Zhao RC, Wang R. Transplantation of human bone marrow-derived mesenchymal stem cells promotes behavioral recovery and endogenous neurogenesis after cerebral ischemia in rats. Brain Res. 2011;1367:103-113. https://doi.org/10.1016/j.brainres.2010.10.063
Noh JE, Oh SH, Park IH, Song J. Intracerebral transplants of GMP-grade human umbilical cord-derived mesenchymal stromal cells effectively treat subacute-phase ischemic stroke in a rodent model. Front. Cell Neurosci. 2020;14:546659. https://doi.org/10.3389/fncel.2020.546659
Kelly S, Bliss TM, Shah AK, Sun GH, Ma M, Foo WC, Masel J, Yenari MA, Weissman IL, Uchida N, Palmer T, Steinberg GK. Transplanted human fetal neural stem cells survive, migrate, and differentiate in ischemic rat cerebral cortex. Proc. Natl Acad. Sci. USA. 2004;101(32):11839-11844. https://doi.org/10.1073/pnas.0404474101
Sullivan R, Duncan K, Dailey T, Kaneko Y, Tajiri N, Borlongan CV. A possible new focus for stroke treatment — migrating stem cells. Expert Opin. Biol. Ther. 2015;15(7):949-958. https://doi.org/10.1517/14712598.2015.1043264
Uchida H, Niizuma K, Kushida Y, Wakao S, Tominaga T, Borlongan CV, Dezawa M. Human muse cells reconstruct neuronal circuitry in subacute lacunar stroke model. Stroke. 2017;48(2):428-435. https://doi.org/10.1161/STROKEAHA.116.014950
Burunova VV, Gisina AM, Kholodenko IV, Lupatov AY, Shragina OA, Yarygin KN. Standardization of biochemical profile of mesenchymal cell materials by probing the level of dehydrogenase activity. Bull. Exp. Biol. Med. 2010;149(4):497-501. https://doi.org/10.1007/s10517-010-0978-0
Namestnikova D, Gubskiy I, Kholodenko I, Melnikov P, Sukhinich K, Gabashvili A, Vishnevskiy D, Soloveva A, Abakumov M, Vakhrushev I, Lupatov A, Chekhonin V, Gubsky L, Yarygin K. Methodological aspects of MRI of transplanted superparamagnetic iron oxide-labeled mesenchymal stem cells in live rat brain. PLoS One. 2017;12(10):e0186717. https://doi.org/10.1371/journal.pone.0186717
Koizumi J, Yoshida Y, Nakazawa T, Ooneda G. Experimental studies of ischemic brain edema. Jpn. J. Stroke. 1986;8(1):1-8. https://doi.org/10.3995/jstroke.8.1
Longa EZ, Weinstein PR, Carlson S, Cummins R. Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke. 1989;20(1):84-91. https://doi.org/10.1161/01.str.20.1.84
Gubskiy IL, Namestnikova DD, Cherkashova EA, Chekhonin VP, Baklaushev VP, Gubsky LV, Yarygin KN. MRI guiding of the middle cerebral artery occlusion in rats aimed to improve stroke modeling. Transl Stroke Res. 2018;9(4):417-425. https://doi.org/10.1007/s12975-017-0590-y
Schaar KL, Brenneman MM, Savitz SI. Functional assessments in the rodent stroke model. Exp. Transl. Stroke Med. 2010;2(1):13. https://doi.org/10.1186/2040-7378-2-13
Huotarinen A, Leino S, Tuominen RK, Laakso A. Rat subthalamic stimulation: Evaluating stimulation-induced dyskinesias, choosing stimulation currents and evaluating the anti-akinetic effect in the cylinder test. MethodsX. 2019;6:2384-2395. https://doi.org/10.1016/j.mex.2019.10.012
Guo Y, Peng Y, Zeng H, Chen G. Progress in mesenchymal stem cell therapy for ischemic stroke. Stem Cells Int. 2021;2021:9923566. https://doi.org/10.1155/2021/9923566
Toyoshima A, Yasuhara T, Kameda M, Morimoto J, Takeuchi H, Wang F, Sasaki T, Sasada S, Shinko A, Wakamori T, Okazaki M, Kondo A, Agari T, Borlongan CV, Date I. Intra-arterial transplantation of allogeneic mesenchymal stem cells mounts neuroprotective effects in a transient ischemic stroke model in rats: analyses of therapeutic time window and its mechanisms. PLoS One. 2015;10(6):e0127302. https://doi.org/10.1371/journal.pone.0127302
Powers WJ, Rabinstein AA, Ackerson T, Adeoye OM, Bambakidis NC, Becker K, Biller J, Brown M, Demaerschalk BM, Hoh B, Jauch EC, Kidwell CS, Leslie-Mazwi TM, Ovbiagele B, Scott PA, Sheth KN, Southerland AM, Summers DV, Tirschwell DL. Guidelines for the early management of patients with acute ischemic stroke: 2019 Update to the 2018 Guidelines for the early management of acute ischemic stroke: A Guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2019;50(12):e344-e418. https://doi.org/10.1161/STR.0000000000000211
Kawabori M, Kuroda S, Ito M, Shichinohe H, Houkin K, Kuge Y, Tamaki N. Timing and cell dose determine therapeutic effects of bone marrow stromal cell transplantation in rat model of cerebral infarct. Neuropathology. 2013;33(2):140-148. https://doi.org/10.1111/j.1440-1789.2012.01335.x
Li N, Wang P, Ma XL, Wang J, Zhao LJ, Du L, Wang LY, Wang XR, Liu KD. Effect of bone marrow stromal cell transplantation on neurologic function and expression of VEGF in rats with focal cerebral ischemia. Mol. Med. Rep. 2014;10(5):2299-2305. https://doi.org/10.3892/mmr.2014.2502
Darsalia V, Allison SJ, Cusulin C, Monni E, Kuzdas D, Kallur T, Lindvall O, Kokaia Z. Cell number and timing of transplantation determine survival of human neural stem cell grafts in stroke-damaged rat brain. J. Cereb. Blood Flow Metab. 2011;31(1):235-242. https://doi.org/10.1038/jcbfm.2010.81
Spronk E, Sykes G, Falcione S, Munsterman D, Joy T, Kamtchum-Tatuene J, Jickling GC. Hemorrhagic transformation in ischemic stroke and the role of inflammation. Front. Neurol. 2021;12:661955. https://doi.org/10.3389/fneur.2021.661955
Komatsu K, Honmou O, Suzuki J, Houkin K, Hamada H, Kocsis JD. Therapeutic time window of mesenchymal stem cells derived from bone marrow after cerebral ischemia. Brain Res. 2010;1334:84-92. https://doi.org/10.1016/j.brainres.2010.04.006
Ma S, Zhong D, Chen H, Zheng Y, Sun Y, Luo J, Li H, Li G, Yin Y. The immunomodulatory effect of bone marrow stromal cells (BMSCs) on interleukin (IL)-23/IL-17-mediated ischemic stroke in mice. J. Neuroimmunol. 2013;257(1-2):28-35. https://doi.org/10.1016/j.jneuroim.2013.01.007
Vu Q, Xie K, Eckert M, Zhao W, Cramer SC. Meta-analysis of preclinical studies of mesenchymal stromal cells for ischemic stroke. Neurology. 2014;82(14):1277-1286. https://doi.org/10.1212/WNL.0000000000000278
Wu Q, Wang Y, Demaerschalk BM, Ghimire S, Wellik KE, Qu W. Bone marrow stromal cell therapy for ischemic stroke: A meta-analysis of randomized control animal trials. Int. J. Stroke. 2017;12(3):273-284. https://doi.org/10.1177/1747493016676617
Haacke EM, Xu Y, Cheng YC, Reichenbach JR. Susceptibility weighted imaging (SWI). Magn. Reson Med. 2004;52(3):612-618. https://doi.org/10.1002/mrm.20198
Xu C, Mu L, Roes I, Miranda-Nieves D, Nahrendorf M, Ankrum JA, Zhao W, Karp JM. Nanoparticle-based monitoring of cell therapy. Nanotechnology. 2011;22(49):494001. https://doi.org/10.1088/0957-4484/22/49/494001
Alvarez-Buylla A, Garcia-Verdugo JM. Neurogenesis in adult subventricular zone. J. Neurosci. 2002;22(3):629-634. https://doi.org/10.1523/JNEUROSCI.22-03-00629.2002
McGinley LM, Kashlan ON, Chen KS, Bruno ES, Hayes JM, Backus C, Feldman S, Kashlan BN, Johe K, Feldman EL. Human neural stem cell transplantation into the corpus callosum of Alzheimer’s mice. Ann. Clin. Transl. Neurol. 2017;4(10):749-755. https://doi.org/10.1002/acn3.443
Sukhinich KK, Kosykh AV, Aleksandrova MA. Differentiation and cell-cell interactions of neural progenitor cells transplanted into intact adult brain. Bull. Exp. Biol. Med. 2015;160(1):115-122. https://doi.org/10.1007/s10517-015-3111-6
Li JM, Zhu H, Lu S, Liu Y, Li Q, Ravenscroft P, Xu YF, Huang L, Ma CM, Bezard E, Zhao RC, Wang RZ, Qin C. Migration and differentiation of human mesenchymal stem cells in the normal rat brain. Neurol. Res. 2011;33(1):84-92. https://doi.org/10.1179/016164110X12670144737819
Sukhinich KK, Namestnikova DD, Gubskii IL, Gabashvili AN, Mel’nikov PA, Vitushev EY, Vishnevskii DA, Revkova VA, Solov’eva AA, Voitkovskaya KS, Vakhrushev IV, Burunova VV, Berdalin AB, Aleksandrova MA, Chekhonin VP, Gubskii LV, Yarygin KN. Distribution and migration of human placental mesenchymal stromal cells in the brain of healthy rats after stereotaxic or intra-arterial transplantation. Bull. Exp. Biol. Med. 2020;168(4):542-551. https://doi.org/10.1007/s10517-020-04750-8
Author information
Authors and Affiliations
Corresponding author
Additional information
Translated from Kletochnye Tekhnologii v Biologii i Meditsine, No. 1, pp. 3-13, March, 2023
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Namestnikova, D.D., Gubskiy, I.L., Cherkashova, E.A. et al. Therapeutic Efficacy and Migration of Mesenchymal Stem Cells after Intracerebral Transplantation in Rats with Experimental Ischemic Stroke. Bull Exp Biol Med 175, 116–125 (2023). https://doi.org/10.1007/s10517-023-05822-1
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10517-023-05822-1